Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Kang

Showing results (21-30 of 502) with videos related to

Pageof 51
Sort By:
Frontiers in Immunology|July 24, 2025
Dopamine as an endogenous regulator of innate immunity in sepsisHaichao Wang, Rui Kang, Daolin Tang
BMJ Oncology|December 1, 2025
KRAS-targeted therapies in cancer: novel approaches and overcoming resistanceDaolin Tang, Guido Kroemer, Rui Kang
Trends in Cancer|December 3, 2024
Selective autophagy receptor hinders antitumor immunityJiao Liu, Rui Kang, Daolin Tang
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2023
Fluorogenic Probes for Intracellular Iron DetectionRunliu Wu, Daolin Tang, Rui Kang
Nature Reviews. Clinical Oncology|March 15, 2024
Targeting cuproplasia and cuproptosis in cancerDaolin Tang, Guido Kroemer, Rui Kang
Trends in Immunology|March 17, 2024
Lipopolysaccharide delivery systems in innate immunityJiao Liu, Rui Kang, Daolin Tang
Journal of Biopharmaceutical Statistics|April 14, 2026
Bayesian quantitative decision-making framework in cell and gene therapy development for rare diseasesRui Kang, Yusuke Yamaguchi, Cong Han
Signal Transduction and Targeted Therapy|June 3, 2021
The STING1 network regulates autophagy and cell deathRuoxi Zhang, Rui Kang, Daolin Tang
Cancer Gene Therapy|September 2, 2021
The KRAS-G12C inhibitor: activity and resistanceJiao Liu, Rui Kang, Daolin Tang
The FEBS Journal|June 6, 2021
Signaling pathways and defense mechanisms of ferroptosisJiao Liu, Rui Kang, Daolin Tang
Pageof 51

Showing results (21-30 of 502) with videos related to

Sort By:
Pageof 51
Frontiers in Immunology|July 24, 2025
Dopamine as an endogenous regulator of innate immunity in sepsisHaichao Wang, Rui Kang, Daolin Tang
BMJ Oncology|December 1, 2025
KRAS-targeted therapies in cancer: novel approaches and overcoming resistanceDaolin Tang, Guido Kroemer, Rui Kang
Trends in Cancer|December 3, 2024
Selective autophagy receptor hinders antitumor immunityJiao Liu, Rui Kang, Daolin Tang
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2023
Fluorogenic Probes for Intracellular Iron DetectionRunliu Wu, Daolin Tang, Rui Kang
Nature Reviews. Clinical Oncology|March 15, 2024
Targeting cuproplasia and cuproptosis in cancerDaolin Tang, Guido Kroemer, Rui Kang
Trends in Immunology|March 17, 2024
Lipopolysaccharide delivery systems in innate immunityJiao Liu, Rui Kang, Daolin Tang
Journal of Biopharmaceutical Statistics|April 14, 2026
Bayesian quantitative decision-making framework in cell and gene therapy development for rare diseasesRui Kang, Yusuke Yamaguchi, Cong Han
Signal Transduction and Targeted Therapy|June 3, 2021
The STING1 network regulates autophagy and cell deathRuoxi Zhang, Rui Kang, Daolin Tang
Cancer Gene Therapy|September 2, 2021
The KRAS-G12C inhibitor: activity and resistanceJiao Liu, Rui Kang, Daolin Tang
The FEBS Journal|June 6, 2021
Signaling pathways and defense mechanisms of ferroptosisJiao Liu, Rui Kang, Daolin Tang
Pageof 51